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Abstract
The alteration in intracellular Zn2+ homeostasis is attributed to the generation of intracellular reactive oxygen
species, which subsequently results in oxidative damage of organelles and cell apoptosis. In this work, the
neurotoxic effects of ZnO hierarchical architectures (nanoparticles and microspheres, the prism-like and flower-like
structures) were evaluated through the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay using
RSC96 Schwann cells as the model. Cell apoptosis and cell cycle were detected using flow cytometry. The
concentration of Zn2+ in the culture media was monitored using atomic absorption spectrometry. The results show
that ZnO nanoparticles and microspheres displayed significant cytotoxic effects on RSC96 Schwann cells in dose-
and time-dependent manners, whereas no or low cytotoxic effect was observed when the cells were treated with
the prism-like and flower-like ZnO. A remarkable cell apoptosis and G2/M cell cycle arrest were observed when
RSC96 Schwann cells were exposed to ZnO nanoparticles and microspheres at a dose of 80 μg/mL for 12 h. The
time-dependent increase of Zn2+ concentration in the culture media suggests that the cytotoxic effects were
associated with the decomposition of ZnO hierarchical architecture and the subsequent release of Zn2+. These
results provide new insights into the cytotoxic effects of complex ZnO architectures, which could be prominently
dominated by nanoscale building blocks.
Keywords: ZnO, Hierarchical architectures, Neurotoxic effect
Background
ZnO nanostructures have attracted global interest because
of their excellent optoelectronic, piezoelectric, ferromag-
netic, and optical properties. Therefore, evaluating the
biocompatibility of ZnO nanostructures is important.
However, contradictory results on the biocompatibility of
ZnO nanostructures were reported in numerous studies
[1-6]. For example, no or low cytotoxic effect was
observed on rat L2 lung epithelial cells and primary rat
lung alveolar macrophage treated with ZnO nanoparticles
(NPs) [2]. ZnO nanowires were shown to be completely
biocompatible on HeLa cells but cytotoxic on L929 cells
at a dose of 100 μg/mL [3]. In vitro experiments indicated
that ZnO NPs have potential applications in cancer diag-
nosis and therapy [7-9]. However, significant cytotoxic
effects were observed when cells were treated with ZnO
nanostructures [10-16]. For example, the treatment of dif-
ferent cells (such as epithelial A549, A431, BEAS-2B cells,
and macrophage RAW 264.7 cells) with ZnO NPs induces
remarkable intracellular oxidative stress and DNA damage
[17-19]. To date, only a few investigations have evaluated
the cytotoxicity of complex ZnO nanostructures
assembled by nanoscale building blocks.
Zn2+ is a vital component of enzymes and proteins and
an ionic signal among various intracellular organelles and
storage depots [20]. It modulates protein function by bind-
ing to and detaching from intracellular zinc-dependent
proteins. Nevertheless, excess free Zn2+ is cytotoxic and
can induce serious neuronal injury [21-23]. Considerable
evidence shows that free Zn2+ in the extracellular fluid
results in amyloid deposition, one of the pathological hall-
marks of Alzheimer’s disease [24,25]. To date, little is
known about the neurotoxic effects of ZnO nanostruc-
tures. In the present study, the neurotoxic effects of ZnO
hierarchical architectures (including NPs and hollow
microspheres consisting of NPs, the prism-like and flower-
like structures) were evaluated using RSC96 Schwann cells
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as the model. RSC96 Schwann cells are the main support-
ive cells of the peripheral nervous system and are respon-
sible for the myelination of axons. Cell viability was
measured through the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) assay, and flow cyto-
metry was employed to analyze cell apoptosis and cell
cycle. The decomposition of ZnO hierarchical architec-
tures in cell culture media was measured using atomic ab-
sorption spectrometry.
Methods
Synthesis of ZnO hierarchical architectures
ZnO with different morphologies (the prism-like, flower-
like structures, and hollow microspheres) was synthe-
sized according to the method reported previously [26].
Briefly, Zn(CH3COO)2•2H2O (0.2195 g, 1 mmol) was
dissolved in 25 mL deionized water in the magnetic stir-
ring, and then histidine (His, 0.1552 g, 1 mmol) was
added into the zinc acetate solution. NaOH (0.88 g, 22
mmol) was dissolved in 15 mL deionized water and
added dropwise into the solution containing zinc acetate
and His. After 15 min stirring, the mixture was trans-
ferred to and sealed in a 50-mL Teflon-lined autoclave,
heated to 150°C for 10 h, then finally cooled to room
temperature. In the series of the synthesis, the amount
of NaOH and His was changed at the designed molar
ratios. The precipitate was collected by the centrifuga-
tion (10,000 rpm, 5 min), washed alternately with the
deionized water and ethanol, and dried in air at 60°C for
4 h. In order to prepare ZnO NPs, Zn(CH3COO)2•2H2O
(0.2195 g, 1 mmol) was dissolved in 37 mL EG. NaOH
(0.1 g, 2.5 mmol) was dissolved in 3 mL deionized water
and added to Zn(CH3COO)2 solution under magnetic
stirring. The mixture was transferred to and sealed in a
50-mL Teflon-lined autoclave and heated to 150°C
for 10 h.
Characterization
The morphology and structure of ZnO hierarchical
architectures obtained were observed through field-
emission scanning electron microscopy (FESEM, Sirion
200, FEI Corp., Eindhoven, Netherlands) and transmis-
sion electron microscopy (TEM, Tecnai G2-20, FEI
Corp., Eindhoven, Netherlands), respectively.
MTT assay of cell viability
ZnO hierarchical architectures were ultrasonically dis-
persed in phosphate buffer solution (PBS) and added to
cell culture media at the designed doses. The cell viabil-
ity was measured using the MTT assay. Briefly, RSC96
Schwann cells were seeded in a 96-well plate at a density
of 1 × 105 cells/mL. The cells grew for 12 h after seeding
and were treated with ZnO hierarchical architectures at
designed doses (4, 8, 40, 80, and 400 μg/mL) for
different times (6, 12, 24, and 48 h). A 20-μL MTT (5
mg/mL) was added to each well and incubated for 4 h
after removing zinc compounds-containing culture
media and washing the cells with PBS three times. Fi-
nally, all media were removed and 150 μL DMSO was
added to each well and shaken for 10 min. The absorb-
ance was read at a wavelength of 550 nm using a Bench-
mark Microplate Reader (Bio-Rad Corp., Hercules, CA,
USA).
Apoptosis and cell cycle analysis
To assay the percentage of apoptotic and necrotic cells,
FITC-annexin V- and propidium iodide (PI)-stained cells
were analyzed using an Annexin V-FITC detection kit
(BD Pharmingen Inc., San Diego, CA, USA) according
to the manufacturer’s instructions. RSC96 Schwann cells
were seeded in a 12-well plate at a density of 1 × 105
cells/mL. The cells were allowed to grow for 12 h after
seeding and were treated with ZnO hierarchical architec-
tures at doses of 8 and 80 μg/mL for 12 h, respectively.
After being washed thrice with ice-cold PBS, the cells
were resuspended in 400 μL binding buffer (10 mM
HEPES/NaOH, pH 7.4, 150 mM NaCl, 5 mM KCl, 1
mM MgCl2, and 1.8 mM CaCl2) at a density of 8 × 10
6
cells/mL. Subsequently, they were filtered with a 100-μm
filter and then co-incubated with 5 μL FITC-annexin V
(25 μg/mL) and 1 μL PI (50 μg/mL) in the absence of
light for 15 min at room temperature. Finally, the fluor-
escence intensities of the stained cells were analyzed
using a FACScalibur Flow cytometer (Becton, Dickinson
and Company, Franklin Lakes, NJ, USA).
To assay the cell cycles, the cells were resuspended in
ice-cold 70% ethanol and then incubated at 4°C for 1 h.
The samples were stored at −20°C for 24 h. After being
centrifuged at 150 × g for 8 min, the cells were washed
twice with ice-cold PBS and then co-incubated with
RNase (60 μg/mL) at 37°C for 30 min. The mixture was
cooled in an ice bath for 2 min to stop the digestion of
RNase. Then, 500 μL PI (50 μg/mL) was added and
incubated in the absence of light for at least 30 min at
4°C. After being filtered with a 100-μm filter, the samples
were transferred and analyzed using a flow cytometer.
Cell cycle was assessed using a FACScan flow cytometer
(BD Biosciences, San Jose, CA, USA), CellQuest software
(version 2.0) and ModFit LT (Verity Software House,
version 2.0, Topsham, ME, USA). The percent-age of
cells in sub-Go/G1, Go/S, and G2/M phases was ana-
lyzed using ModFit LT (Verity Software House,
version 2.0).
Measurement of Zn2+ concentration in culture media
Culture media were collected and centrifuged (10,000
rpm, 5 min) after cells were incubated with ZnO
hierarchical architectures at designed times and doses.
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The suspension was carefully collected for the measure-
ment of Zn2+ concentration using atomic absorption
spectrometry.
Results and discussion
The morphologies of ZnO hierarchical architectures
were characterized through scanning electron micros-
copy (SEM) and TEM observation. As shown in
Figures 1a and 2a, monodispersed spherical ZnO NPs
with an average diameter of ca. 35 nm were obtained.
Hollow ZnO microspheres with an average diameter of ca.
2.7 μm were also obtained (Figure 1b). Numerous ZnO
NPs were adsorbed on the rough surface of the micro-
spheres. As shown in the inset of Figure 1b, the ZnO
microspheres consisted of numerous NPs that are slightly
larger than those in Figure 1a. The TEM image in
Figure 2b further confirms the hollow structure of the
microspheres consisting of NPs that are ca. 45 nm in diam-
eter (Figure 2b). A hexahedral, prism-like ZnO was synthe-
sized with a sharp but irregular tip (Figures 1c and 2c).
The prism-like structure was ca. 2.5 to 6.0 μm in diameter
and ca. 18.0 to 60.0 μm in length. Figures 1d and 2d show
SEM and TEM images of the flower-like structure which
consisted of sword-like leaves and prism-like pistils. Both
the leaves and the prism-like pistils were ca. 500 to 600 nm
in diameter (or in width) and several microns in length.
The cytotoxicity of the ZnO hierarchical architectures
on RSC96 Schwann cells was evaluated via MTT assay.
As shown in Figure 3a,b, no or very low cytotoxic effect
was observed when RSC96 Schwann cells were treated
with the prism-like and flower-like ZnO for 12 h at dif-
ferent doses (4, 8, 40, 80, and 400 μg/mL). Significant
cytotoxic effects were observed when the treatment was
prolonged up to 48 h at the high dose of 400 μg/mL.
Cell viability sharply decreased to ca. 58.2% and 52.8%
compared with that of the control. Dose- and time-
dependent cytotoxic effects were observed when the
cells were treated with ZnO NPs and microspheres. For
example, a slight cytotoxic effect was observed when the
cells were treated with ZnO NPs for 24 h at low doses
(lower than 40 μg/mL). Cell viability was decreased to
ca. 86.5% at an exposed dose of 40 μg/mL compared
with that of the control. Acute cytotoxic effects were
detected when the dose of the ZnO NPs was increased
to 400 μg/mL, resulting in a sharp decrease in cell viabil-
ity to ca. 25% after 12 h treatment. Almost complete
death of cells occurred after 24 h of treatment. Remark-
able time-dependent cytotoxic effects were observed at
high doses (higher than 80 μg/mL). After being treated
with ZnO NPs for 6 to 48 h, the cell viability was
decreased from ca. 74.1% to 52.0% and from ca. 76.7% to
1.7% at doses of 80 and 400 μg/mL, respectively.
It is noteworthy that both dose- and time-dependent
cytotoxic effects were more significant when RSC96
Schwann cells were treated with ZnO microspheres. For
example, no cytotoxic effect was observed when the cells
Figure 1 SEM images of the ZnO hierarchical architectures used for the cytotoxic assessment on RSC96 Schwann cells. (a) ZnO NPs, (b)
hollow ZnO microspheres, (c) prism-like ZnO, and (d) flower-like ZnO.
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were treated at low doses (lower than 8 μg/mL) for 48 h.
The significant cytotoxic effects were observed when the
dose was higher than 80 μg/mL. For example, cell viabil-
ity was decreased to ca. 57.8% when RSC96 Schwann
cells were treated with ZnO microspheres at a dose of
400 μg/mL for 6 h. Time-dependent cytotoxic effects
were observed when the cells were treated at high doses
(higher than 40 μg/mL) for 48 h. For example, cell via-
bility decreased to ca. 83.2%, 53.5%, 34.8%, and 6.8%
when the cells were treated at a dose of 80 μg/mL for 6,
12, 24, and 48 h, respectively.
To investigate the cytotoxic effects of ZnO hierarch-
ical architectures on RSC96 Schwann cells, cell apop-
tosis and necrosis were measured through a flow
cytometry. As shown in Figure 4, RSC96 cells treated
with ZnO hierarchical architectures at a dose of 8 μg/
mL for 12 h grew normally and did not display apop-
tosis or necrosis, suggesting the absence of significant
cytotoxic effects. When the dose was increased to 80
μg/mL, a low apoptosis rate of ca. 24.7% and 6.4% was
observed corresponding to the treatment with the
prism-like and flower-like ZnO, respectively. By con-
trast, a significant apoptosis rate of ca. 51.3% and 39.2%
was detected when the cells were treated with ZnO
NPs and microspheres at a dose of 80 μg/mL for 12 h,
respectively. Furthermore, a significant necrosis rate of
ca. 16.4% was observed in the cells treated with ZnO
microspheres.
The cell cycle distribution was further analyzed to
evaluate the cytotoxic effects of ZnO hierarchical archi-
tectures. Most cells are usually in the growth phase
(G1), wherein various enzymes (especially those needed
for DNA replication) are synthesized. In the subsequent
S phase, DNA synthesis is completed to double the
chromosomes for division. The G2 phase starts from the
end of DNA synthesis until the beginning of mitosis, in-
volving the synthesis of microtubules. The M phase lasts
throughout the procedure during which the mother cell
is divided into two separate but identical daughter cells
[27]. In the present study, the major cell population was
found in the G1 and S phases in the control group.
However, a significant increase of cell population in
G2/M phase, accompanied by a decrease of cell popula-
tion in the G1 and S phases, was observed when RSC96
Schwann cells were treated with ZnO hierarchical archi-
tectures at a dose of 8 μg/mL for 12 h (Table 1). These
Figure 2 TEM images of the ZnO hierarchical architectures used for the cytotoxic assessment on RSC96 Schwann cells. (a) ZnO NPs, (b)
hollow ZnO microspheres, and (c) prism-like ZnO, and (d) flower-like ZnO.
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results suggest that the slight G2/M cell cycle arrest
was induced by the low-dose treatment of ZnO hier-
archical architectures, although no significant cytotoxic
effect was detected according to the MTT assay. The
population of cells in the G2/M phase was further
increased when the cells were treated with ZnO
hierarchical architectures at a dose of 80 μg/mL
(Table 1), suggesting a more serious G2/M cell cycle ar-
rest than that at the lower dose. These results show that
cell cycle was significantly influenced by the treatment
of ZnO hierarchical architectures because of serious









































































































































































(a) Treatment time: 6 h (b) Treatment time: 12 h
(c) Treatment time: 24 h (d) Treatment time: 48 h
Figure 3 Effects of ZnO hierarchical architectures on cell viability of RSC96 Schwann cells (n=5). (a) Treatment time for 6 h, (b) treatment




















































































(a) 8 (b) 80 μg/mL
Figure 4 Flow cytometer analysis of RSC96 Schwann cells treated with ZnO hierarchical architectures for 12 h. (a) at an exposed dose of
8 μg/mL and (b) at an exposed dose of 80 μg/mL.
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The decomposition of ZnO hierarchical architectures
was measured by monitoring the change of Zn2+ con-
centration in the culture media at different time inter-
vals via atomic absorption spectroscopy. As shown in
Figure 5, a significant enhancement of Zn2+ concentra-
tion was observed with increasing incubation time. This
result suggests that the decomposition process occurred
during the incubation period. It is noteworthy that the
release of Zn2+ in the ZnO NPs-treated group was lower
than that in the other groups at a dose of 8 μg/mL, but
higher than in the prism-like and flower-like ZnO-
treated group at a dose of 80 μg/mL. The highest Zn2+ con-
centration was observed in the ZnO microspheres-treated
group at both tested doses (e.g., ca. 3.7 to 9.6 μg/mL at time
intervals from 6 to 48 h at a dose of 80 μg/mL). These
results suggest that at a dose of 80 μg/mL, the release of
Zn2+ from both ZnO NPs and microspheres was faster
than from the flower-like and prism-like ZnO. This result
is consistent with the cytotoxic effect observed via the
MTTassay.
Compared with bulk counterparts, more atoms are
located on the surfaces of smaller NPs, which can inter-
act with biological systems more effectively [28]. In the
present work, ZnO NPs and hollow microspheres con-
sisting of NPs displayed more significant cytotoxic
effects in dose- and time-dependent manners on RSC96
Schwann cells than the bulk prism-like and flower-like
structures. This implies that the cytotoxic effects of
complex architectures are most likely predominated by
the nanoscale building blocks. The precise cytotoxic
mechanisms of ZnO nanostructures still remain indis-
tinct. ZnO NPs can induce a significant accumulation of
intracellular reactive oxygen species (ROS) in various
cells (such as monocytes and lymphocytes and WIL2-NS
human lymphoblastoid cells) in a size-dependent man-
ner. This treatment of ZnO NPs results in the direct al-
teration of mitochondrial functionality, increase of
intracellular Ca2+ level, and expression of genes involved
in apoptosis and oxidative stress responses [29-31]. In
the present work, ZnO NPs and microspheres induced
significant cell apoptosis in a dose-dependent manner.
The treatment of RSC96 cells with ZnO hierarchical
architectures resulted in a remarkable G2/M cell cycle
arrest, even at a sublethal dose (8 μg/mL), implying the
early DNA damage. Furthermore, the release of Zn2+ in
the cell culture media was consistent with the cytotoxic
effect of ZnO hierarchical architectures on RSC96
Schwann cells. Alterations in Zn2+ homeostasis dis-
played powerful stimulatory effects on multiconductance
cation channels in the inner mitochondrial membrane
and ROS generation. A loss of Zn2+ homeostasis may re-
sult in cell apoptosis or necrosis [16,32]. Moreover, the
effects of Zn2+ level on Ca2+ homeostasis were also
reported which is another crucial signal pathway closely
related to cell apoptosis and necrosis [31,33]. The effects
of ZnO NPs on the cell cycle have rarely been studied.
Table 1 Cell cycle analysis of RSC 96 Schwann cells after treatment of ZnO hierarchical architectures for 12 h
Group G1 (%) G2/M (%) S (%)
8 μg/mL 80 μg/mL 8 μg/mL 80 μg/mL 8 μg/mL 80 μg/mL
Control 47.25 ± 0.07 13.55 ± 0.07 39.2 ± 0.14
ZnO NPs 46.4 ± 1.43 44.5 ± 0.37 19.45 ± 2.18 21.82 ± 0.95 34.15 ± 2.60 33.6 ± 1.27
ZnO microspheres 45.78 ± 1.47 38.68 ± 1.75 16.88 ± 3.15 22.7 ± 3.09 37.35 ± 4.50 38.65 ± 1.80
Prism-like ZnO 47.53 ± 1.00 42.75 ± 0.75 18.43 ± 1.23 21.35 ± 1.88 34.03 ± 1.37 35.85 ± 1.32
Flower-like ZnO 46.05 ± 0.48 40.88 ± 1.32 18.5 ± 0.59 22.55 ± 1.86 35.45 ± 0.39 36.55 ± 1.79
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Figure 5 Changes of Zn2+ concentration in the culture medium at different treatment times of ZnO architectures. (a) at tested dose of
8 μg/mL and (b) at tested dose of 80 μg/mL.
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Wang et al. [34] reported that the exposure of human
embryonic kidney HEK293 cells to SiO2 NPs results in
the accumulation of cells in the G2/M phase in a dose-
dependent manner. AshaRani et al. [35] found that Ag
NPs caused a concentration-dependent increase of cell
population in the G2/M phase in both normal human
lung fibroblast IMR90 cells and human glioblastoma
U251cells.
Conclusions
In summary, the cytotoxic effects of ZnO hierarchical
architectures, such as NPs and hollow microspheres
consisting of NPs, the prism-like and flower-like struc-
tures, were evaluated using RSC96 Schwann cells as the
model. The ZnO NPs and microspheres displayed sig-
nificant cytotoxic effects on RSC96 Schwann cells in
time- and concentration-dependent manners. The treat-
ment of cells with ZnO NPs and microspheres induced
remarkable cell apoptosis and G2/M cell cycle arrest
which were associated with the decomposition of ZnO
hierarchical architectures and the subsequent release of
Zn2+ in the culture media. These results provide new
insights into the cytotoxic effects of complex architec-
tures that could be prominently dominated by nanoscale
building blocks.
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